Linking pages
- FDA Approves Alzheimer’s Drug Lecanemab Intended To Tackle The Root Of The Condition And Slow Cognitive Decline Amid Safety Concerns - Awakened Species https://awakenedspecies.com/fda-approves-alzheimers-drug-lecanemab-intended-to-tackle-the-root-of-the-condition-and-slow-cognitive-decline-amid-safety-concerns/ 134 comments
- Alzheimer's drug lecanemab hailed as momentous breakthrough - BBC News https://www.bbc.co.uk/news/health-63749586 116 comments
- Alzheimer’s Drug May Benefit Some Patients, New Data Shows - The New York Times https://www.nytimes.com/2022/11/29/health/lecanemab-alzheimers-drug.html 83 comments
- Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial | Alzheimer's Research & Therapy | Full Text https://alzres.biomedcentral.com/articles/10.1186/s13195-024-01482-z 24 comments
- New studies suggest millions with mild cognitive impairment go undiagnosed, often until it’s too late https://theconversation.com/new-studies-suggest-millions-with-mild-cognitive-impairment-go-undiagnosed-often-until-its-too-late-216892 11 comments
- Alzheimer's: Is lecanemab the next great weapon against it? https://www.medicalnewstoday.com/articles/lecanemab-why-a-new-alzheimers-drug-has-drawn-praise-and-some-concern#Clinically-meaningful-results 6 comments
- The false hope of the new Alzheimer's drugs - UnHerd https://unherd.com/2024/01/the-false-hope-of-the-new-alzheimers-drugs/ 2 comments
- Experimental drug appears to slow progression of Alzheimer's disease in clinical trial but raises safety concerns | CNN https://www.cnn.com/2022/11/29/health/lecanemab-alzheimers-drug-study/index.html 0 comments
- FDA approves new Alzheimer’s drug that appears to slow disease https://www.nbcnews.com/health/health-news/fda-approves-alzheimers-drug-appears-slow-disease-rcna62928 0 comments
- FDA approves breakthrough Alzheimer’s drug Lecanemab | US news | The Guardian https://www.theguardian.com/us-news/2023/jan/06/fda-approves-breakthrough-alzheimers-drug-lecanemab 0 comments
- FDA approves new Alzheimer’s treatment despite risks, unclear benefits | Ars Technica https://arstechnica.com/science/2023/01/fda-approves-new-alzheimers-treatment-despite-risks-unclear-benefits/ 0 comments
- Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population | The Journal of Prevention of Alzheimer's Disease https://link.springer.com/article/10.14283/jpad.2023.131 0 comments
- Nearly Everyone With Mild Cognitive Impairment Goes Undiagnosed | WIRED https://www.wired.com/story/nearly-everyone-with-mild-cognitive-impairment-goes-undiagnosed/ 0 comments
Related searches:
Search whole site: site:www.nejm.org
Search title: Lecanemab in Early Alzheimer’s Disease | NEJM
See how to search.